Director’s Address:

Dear Friends,

Glensmith Labs is extension of my dream to have fully integrated Pharmaceutical operations in both Domestic and overseas market.

Having successfully established my Manufacturing capabilities under Skymap banner and developing marketing muscles with all India Distribution of Biochem, a Division of Zydus Cadila, now Glensmith Labs is the first step to establish my own brand equity in market.

Glensmith Labs is into marketing Generic Drugs in Indian domestic market and it is my vision to develop this entity into an INR 150 Crore business in coming 5 years. Glensmith Labs will foray into all market segments gradually and create a niche for itself on strengths of its Quality, affordability and efficacy.